The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers. / Nøhr, Martha Kampp; Hansen, Steen Honoré; Brodin, Birger; Holm, René; Nielsen, Carsten Uhd.

In: European Journal of Pharmaceutical Sciences, Vol. 51, 23.01.2014, p. 1-10.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nøhr, MK, Hansen, SH, Brodin, B, Holm, R & Nielsen, CU 2014, 'The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers', European Journal of Pharmaceutical Sciences, vol. 51, pp. 1-10. https://doi.org/10.1016/j.ejps.2013.08.034

APA

Nøhr, M. K., Hansen, S. H., Brodin, B., Holm, R., & Nielsen, C. U. (2014). The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences, 51, 1-10. https://doi.org/10.1016/j.ejps.2013.08.034

Vancouver

Nøhr MK, Hansen SH, Brodin B, Holm R, Nielsen CU. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers. European Journal of Pharmaceutical Sciences. 2014 Jan 23;51:1-10. https://doi.org/10.1016/j.ejps.2013.08.034

Author

Nøhr, Martha Kampp ; Hansen, Steen Honoré ; Brodin, Birger ; Holm, René ; Nielsen, Carsten Uhd. / The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers. In: European Journal of Pharmaceutical Sciences. 2014 ; Vol. 51. pp. 1-10.

Bibtex

@article{99640c50442b4038a22920511a02c17e,
title = "The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers",
abstract = "Vigabatrin is an anti-epileptic drug substance. The oral bioavailability of vigabatrin is high (60-70%), however, little is known about the mechanism(s) mediating the intestinal absorption. The aim of the present study was to identify which solute carrier(s) are involved in the absorption of vigabatrin in Caco-2 cells, a cell culture model of the small intestinal epithelium. The uptake and transepithelial flux of vigabatrin was measured using an LC-MS method for quantification. Transepithelial transport of vigabatrin was shown to be proton-dependent and polarized in the apical-to-basolateral (A-B) direction. The A-B flux of vigabatrin had a saturable component and a passive component, indicating the presence of a carrier system in parallel with a passive permeability. The Michaelis constant, Km, of the transepithelial A-B flux of vigabatrin was estimated to be 32.8±7.4mM (n=3-5), whereas the Km of the apical uptake was found to be 12.7±3.7mM (n=3). The carrier-mediated transepithelial A-B flux of vigabatrin accounted for 80-95% (50.0-1.0mM) of the total A-B flux. The transepithelial A-B flux (as well as apical uptake) of vigabatrin was significantly decreased upon addition of substrates or inhibitors of the human proton-coupled amino acid transporter (hPAT1) to the apical solution. The present study indicates that the transepithelial A-B flux of vigabatrin is mainly mediated by hPAT1 in Caco-2 cells at dose-relevant concentrations.",
author = "N{\o}hr, {Martha Kampp} and Hansen, {Steen Honor{\'e}} and Birger Brodin and Ren{\'e} Holm and Nielsen, {Carsten Uhd}",
note = "Copyright {\textcopyright} 2013. Published by Elsevier B.V.",
year = "2014",
month = jan,
day = "23",
doi = "10.1016/j.ejps.2013.08.034",
language = "English",
volume = "51",
pages = "1--10",
journal = "Norvegica Pharmaceutica Acta",
issn = "0928-0987",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers

AU - Nøhr, Martha Kampp

AU - Hansen, Steen Honoré

AU - Brodin, Birger

AU - Holm, René

AU - Nielsen, Carsten Uhd

N1 - Copyright © 2013. Published by Elsevier B.V.

PY - 2014/1/23

Y1 - 2014/1/23

N2 - Vigabatrin is an anti-epileptic drug substance. The oral bioavailability of vigabatrin is high (60-70%), however, little is known about the mechanism(s) mediating the intestinal absorption. The aim of the present study was to identify which solute carrier(s) are involved in the absorption of vigabatrin in Caco-2 cells, a cell culture model of the small intestinal epithelium. The uptake and transepithelial flux of vigabatrin was measured using an LC-MS method for quantification. Transepithelial transport of vigabatrin was shown to be proton-dependent and polarized in the apical-to-basolateral (A-B) direction. The A-B flux of vigabatrin had a saturable component and a passive component, indicating the presence of a carrier system in parallel with a passive permeability. The Michaelis constant, Km, of the transepithelial A-B flux of vigabatrin was estimated to be 32.8±7.4mM (n=3-5), whereas the Km of the apical uptake was found to be 12.7±3.7mM (n=3). The carrier-mediated transepithelial A-B flux of vigabatrin accounted for 80-95% (50.0-1.0mM) of the total A-B flux. The transepithelial A-B flux (as well as apical uptake) of vigabatrin was significantly decreased upon addition of substrates or inhibitors of the human proton-coupled amino acid transporter (hPAT1) to the apical solution. The present study indicates that the transepithelial A-B flux of vigabatrin is mainly mediated by hPAT1 in Caco-2 cells at dose-relevant concentrations.

AB - Vigabatrin is an anti-epileptic drug substance. The oral bioavailability of vigabatrin is high (60-70%), however, little is known about the mechanism(s) mediating the intestinal absorption. The aim of the present study was to identify which solute carrier(s) are involved in the absorption of vigabatrin in Caco-2 cells, a cell culture model of the small intestinal epithelium. The uptake and transepithelial flux of vigabatrin was measured using an LC-MS method for quantification. Transepithelial transport of vigabatrin was shown to be proton-dependent and polarized in the apical-to-basolateral (A-B) direction. The A-B flux of vigabatrin had a saturable component and a passive component, indicating the presence of a carrier system in parallel with a passive permeability. The Michaelis constant, Km, of the transepithelial A-B flux of vigabatrin was estimated to be 32.8±7.4mM (n=3-5), whereas the Km of the apical uptake was found to be 12.7±3.7mM (n=3). The carrier-mediated transepithelial A-B flux of vigabatrin accounted for 80-95% (50.0-1.0mM) of the total A-B flux. The transepithelial A-B flux (as well as apical uptake) of vigabatrin was significantly decreased upon addition of substrates or inhibitors of the human proton-coupled amino acid transporter (hPAT1) to the apical solution. The present study indicates that the transepithelial A-B flux of vigabatrin is mainly mediated by hPAT1 in Caco-2 cells at dose-relevant concentrations.

U2 - 10.1016/j.ejps.2013.08.034

DO - 10.1016/j.ejps.2013.08.034

M3 - Journal article

C2 - 24008184

VL - 51

SP - 1

EP - 10

JO - Norvegica Pharmaceutica Acta

JF - Norvegica Pharmaceutica Acta

SN - 0928-0987

ER -

ID: 50799202